`

Tagged: safety evaluations

Cell and gene advanced therapy in the Battle for Lysosomal Storage Disease

April 8th, 2021 | safety evaluations

Emerging cell and gene therapy may offer sustained long-term correction for LSD patients Dr. Maria Niu Lysosomal storage diseases (LSDs) are rare inherited metabolic diseases and characterized by the accumulation of substrates in excess in various organs’ cells due to lysosomes’ defective functioning. The combined incidence of LSDs is between 1 in 5000 to 1 […]

Pin It on Pinterest